MiNK Therapeutics Inc

NASDAQ:INKT 4:00:00 PM EDT

14.59

+0.32 (+2.24%)

7:59:21 PM EDT: $14.60 +0.01 (+0.07%)

MiNK Therapeutics Inc Stock, NASDAQ:INKT

149 5th Avenue, Suite 500, New York, New York 10010

United States of America

Phone: +1.212.994.8250

Number of Employees: 23

http://www.minktherapeutics.com

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.